Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration
about
Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Evaluation of serum concentrations achieved with an empiric once-daily tobramycin dosage regimen in children and adults with cystic fibrosis.Pharmacokinetics and pharmacodynamics of antibacterial agents.Intensive care management of the patient with cystic fibrosis.Pharmacokinetics and pharmacodynamics of once-daily administration of intravenous tobramycin in adult patients with cystic fibrosis hospitalized for an acute pulmonary exacerbation.Update on antibiotics for infection control in cystic fibrosis.Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.Once daily dosing of aminoglycosides in pediatric cystic fibrosis patients: a review of the literatureOptimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis.Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulation.Pharmacokinetics of once and twice daily dosing of intravenous tobramycin in paediatric patients with cystic fibrosis.Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.
P2860
Q34297656-166CD1AD-7472-45E5-BB1B-F325C6B6206EQ36191093-80733951-A4B4-4541-A745-D67C39BA707BQ36911111-2AB2FFBC-E237-494C-B031-A3C65882281FQ37149666-F5F787AD-A16E-46AE-9EAA-CC4A13A0A35BQ37263821-C402E92F-626C-4919-A2C9-EC3B65F578E4Q37608274-D5BA0A56-2132-4AC5-8241-19BF0E87A075Q37661512-8D815018-F91F-4650-8D7D-E9D7EC11B795Q37940005-00B759C0-6E42-4777-BC24-2BDD72B45C00Q38051316-D4B44BDC-3176-4533-95AF-0F057D60395BQ38133781-C7E28172-8185-4B99-9D9F-003C8BFF2336Q38823748-50DEF90C-4490-4589-9011-F833679DCED5Q39097052-17EB42C6-B42A-44F7-9839-DFC84AB1F005Q42017846-536F6D21-300F-4A54-8C37-A15BFB81424BQ44746169-88555640-C3FE-45DB-8B08-308C37C7BA32Q45019997-6E365B10-BDC6-4A3E-8CBA-F25BF416F844Q51933433-E4560C50-5B8E-4254-B0B4-0F42582ABC79Q55015958-ED744DC0-282B-4E7F-9ECD-3AADBBCCF095
P2860
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetics of tobramycin ...... for once-daily administration
@ast
Pharmacokinetics of tobramycin ...... for once-daily administration
@en
type
label
Pharmacokinetics of tobramycin ...... for once-daily administration
@ast
Pharmacokinetics of tobramycin ...... for once-daily administration
@en
prefLabel
Pharmacokinetics of tobramycin ...... for once-daily administration
@ast
Pharmacokinetics of tobramycin ...... for once-daily administration
@en
P2093
P2860
P1476
Pharmacokinetics of tobramycin ...... for once-daily administration
@en
P2093
B J Shapiro
P M Beringer
R W Jelliffe
P2860
P304
P356
10.1128/AAC.44.4.809-813.2000
P407
P577
2000-04-01T00:00:00Z